Research Identified Key Traits of Hypermobile Ehlers-Danlos
New findings highlight unique physiological markers and treatment responses for patients with this syndrome.
Updated on Sept. 23, 2026 in Arthritis
Live Poll
Should medical researchers prioritize studying multi-system symptoms over focusing solely on pain management?
Three new studies have mapped distinct physiological characteristics and symptom patterns in hypermobile Ehlers-Danlos syndrome (hEDS), which represents 90% of all Ehlers-Danlos cases. This research offers new insight into the condition as experts work toward a formal diagnostic test.
Why it matters
Understanding these physiological differences is a critical step toward addressing the lack of known genetic causes for hEDS and improving disease management. These findings help clarify why patients experience varied symptoms even in the absence of chronic pain.
Researchers analyzed blood, urine, and skin biosamples from over 80 participants to compare those with hypermobile Ehlers-Danlos syndrome, hypermobility spectrum disorders, and non-hypermobile individuals. This analysis identified distinct androgen levels in women with the syndrome.
The players
Carle Health
A healthcare provider based in Urbana, Illinois, involved in clinical research.
St. Jude Research Hospital
A pediatric treatment and research facility in Memphis.
University of Arizona
A research university in Arizona contributing to medical studies.
The details
The research suggests that physiological and symptom-based differences exist even when chronic pain is absent, such as varying responses to sleep apnea treatments. While hypermobile individuals show high CPAP compliance for sleep apnea, their daytime sleepiness often does not improve as effectively as it does in non-hypermobile patients. These studies also highlight that androgen levels differ in women with hEDS, a key finding as scientists look for biological signatures to replace the current lack of identifiable genes.
Timeline
The research was published in 2026.
Health Landscape
These findings provide a new diagnostic foundation for the ongoing search for the genetic basis of hypermobile Ehlers-Danlos syndrome. By identifying specific physiological markers, the research marks a departure from purely symptom-based clinical observations.
Patients with hypermobile symptoms should discuss these findings with their physician, particularly if they experience lingering sleepiness despite using CPAP therapy for apnea. Recognizing that symptoms can occur without pain may help in identifying the need for a comprehensive assessment.
The takeaway
Physiological markers, including hormone level differences, are increasingly recognized as central to understanding Ehlers-Danlos syndrome. Patients are encouraged to track specific symptom patterns, such as daytime sleepiness, and review them during regular appointments with their primary care provider.
Further reading
For more information on managing chronic joint conditions, visit our Arthritis section.
More information
Review the full Journal study on androgen levels for technical details on these findings.
Source note: This article includes information reported by Technology Networks.
Live Poll
Should medical researchers prioritize studying multi-system symptoms over focusing solely on pain management?
